Temasek bets on Motilal Oswal PE-backed diagnostics company

 Temasek bets on Motilal Oswal PE-backed diagnostics company
Goa-based Molbio Diagnostics, known for its ‘Truenat’ technology for real-time testing for diseases such as Covid-19 and dengue, said Monday that Singapore state investment firm Temasek has decided to invest $85 million (Rs 693 crore) in the company. The fresh funds from Temasek, along with those from existing investors such […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest